Berkeley Lights, Inc.

Short description

BLI is a digital cell biology company developing platforms for acceleration of discovery, development, and delivery of cell-based products and therapies. The platform is ideally suited for CLD, CTD, and AbD workflows. It provides 100-fold increase in insights, 10x faster, at a fraction of the costs.

About us

Berkeley Lights (BLI) is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.

Berkeley Lights’ Beacon and Lightning systems and Culture Station instrument are for research use only. Not for use in diagnostic procedures.